- Home
- TIL vs NAAS Comparison
TIL vs NAAS Comparison
Compare TIL & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TIL | NAAS |
|---|---|---|
| Founded | 2018 | 2019 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.7M | 42.1M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | TIL | NAAS |
|---|---|---|
| Price | $11.43 | $3.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $100.67 | N/A |
| AVG Volume (30 Days) | ★ 62.3K | 34.1K |
| Earning Date | 11-13-2025 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $21,817,052.00 |
| Revenue This Year | N/A | $378.49 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.69 | $1.96 |
| 52 Week High | $42.79 | $40.32 |
Technical Indicators
Market Signals| Indicator | TIL | NAAS |
|---|---|---|
| Relative Strength Index (RSI) | 42.98 | 48.69 |
| Support Level | $10.72 | $3.31 |
| Resistance Level | $11.63 | $4.10 |
| Average True Range (ATR) | 0.58 | 0.23 |
| MACD | 0.27 | -0.01 |
| Stochastic Oscillator | 67.39 | 34.52 |
Price Performance
Historical ComparisonAbout TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators, a wide range of offline services that simplify the daily operations of charging station operators, and non-charging services such as food and beverage services to station operators.